InvAscent

InvAscent's India Life Sciences invests $16m in Pregna for minority stake

Mumbai headquartered-Pregna specializes in research, development and manufacturing of intrauterine contraception and treatments. It sells its products across 140 countries.

Women’s reproductive health company Pregna International has raised its first private equity funding of ~$16m (INR 1.3bn) from India Life Sciences Fund III (ILSF III) for a minority stake. India Life Sciences Fund is managed by private equity firm InvAscent.
Pregna makes intra uterine device (IUD) manufacturers globally.

The company said it will use the capital to build new products, class III medical devices manufacturing, long-term drug delivery applications, and global market reach.Founded in the 1990s by Late Shyamsunder Taparia, Jaiprakash Taparia and Mukul Taparia, Pregna makes contraception device player such as IUD and makes other reproductive and women’s health products. It sells its products across 140 countries, the company said.

Pregna was advises by Unaprime Investment Advisors, the Indian member firm of Cognos.

This investment will fuel Pregna’s growth and enable them to address the evolving needs of women across the globe. The company and InvAscent will use their resources and expertise to drive greater access to reproductive healthcare options, raise awareness, and make a positive impact on women’s health Sumit Gupta, MD, InvAscent

The company is well-positioned to capitalize on its enhanced manufacturing capabilities, expanding product portfolio, and geographical reach Mukul Taparia, MD, Pregna

Deep Mishra